AbCellera Biologics Inc.
ABCL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
In the last 90 days, AbCellera Biologics Inc. insiders filed 4 open-market purchases and 0 sales; 150 institutions reported holding it in 13F filings for Q2 2026, worth $908.8M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in AbCellera Biologics Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- +28 vs. Q1 2021
- Shares held
- 90.6M
- +19.4M (+27.2%) vs. Q1 2021
- Total value
- $1.99B
- −$431.1M (−17.8%) vs. Q1 2021
- New holders
- 48
- 50 more added
- Sold out
- 20
- 8 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ABCL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 150 | $908.8M |
| Q1 2026 | 138 | $434.0M |
| Q4 2025 | 144 | $370.6M |
| Q3 2025 | 141 | $524.6M |
| Q2 2025 | 128 | $370.6M |
| Q1 2025 | 129 | $280.1M |
| Q4 2024 | 146 | $333.9M |
| Q3 2024 | 139 | $274.6M |
| Q2 2024 | 148 | $338.3M |
| Q1 2024 | 154 | $547.4M |
| Q4 2023 | 143 | $681.1M |
| Q3 2023 | 138 | $551.8M |
| Q2 2023 | 170 | $809.1M |
| Q1 2023 | 183 | $980.7M |
| Q4 2022 | 203 | $1.30B |
| Q3 2022 | 190 | $1.21B |
| Q2 2022 | 162 | $1.26B |
| Q1 2022 | 130 | $1.10B |
| Q4 2021 | 124 | $1.63B |
| Q3 2021 | 116 | $1.98B |
| Q2 2021 | 114 | $1.99B |
| Q1 2021 | 86 | $2.42B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding AbCellera Biologics Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Intellectus Partners, LLC | 1,206,979 | $26.6M | 5.99% | +1,206,979 | New |
| Falcon Edge Capital, LP | 1,338,253 | $29.4M | 1.88% | −1,088,545−44.9% | Reduced |
| Parametric Portfolio Associates LLC | 1,500,000 | $33.0M | 0.02% | +1,500,000 | New |
| Credit Suisse AG | 2,635,773 | $58.0M | 0.05% | +364,973+16.1% | Added |
| Baillie Gifford & Co | 2,725,197 | $60.0M | 0.03% | +1,569,844+135.9% | Added |
| Guardian Capital Advisors LP | 3,975,994 | $81.4M | 8.35% | +3,975,994 | New |
| Founders Fund VII Management, LLC | 3,773,530 | $83.0M | 79.60% | 00.0% | Unchanged |
| Harvard Management Co Inc | 4,105,095 | $90.3M | 5.20% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 6,223,019 | $136.9M | 1.40% | −1,977,749−24.1% | Reduced |
| Capital International Investors | 6,894,089 | $151.7M | 0.03% | +5,097,178+283.7% | Added |
| SB Management Ltd | 9,817,190 | $216.0M | 2.54% | +2,000,000+25.6% | Added |
| Allianz Asset Management GmbH | 9,929,704 | $218.5M | 0.20% | +9,929,704 | New |
| Baker Bros. Advisors LP | 10,450,180 | $229.9M | 1.01% | 00.0% | Unchanged |
| Capital World Investors | 13,415,437 | $295.1M | 0.05% | +9,254,567+222.4% | Added |
| Viking Global Investors LPSuperinvestorViking Global Investors | 0 | $0 | 0.00% | −19,083,744−100.0% | Sold out |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 0 | $0 | 0.00% | −659,750−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −524,690−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −225,000−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −77,638−100.0% | Sold out |
| Skandinaviska Enskilda Banken AB (publ) | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −27,366−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −26,592−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −20,800−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −15,755−100.0% | Sold out |
| Avidian Wealth Solutions, LLC | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −10,593−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Paragon Advisors, LLC | 0 | $0 | 0.00% | −8,840−100.0% | Sold out |
| Lumina Fund Management LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −2,395−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −602−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −435−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −166−100.0% | Sold out |